Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ari J Cohen

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Ochsner Journal|March 24, 2017
Negligible Oval Cell Proliferation Following Ischemia-Reperfusion Injury With and Without Partial HepatectomyEk Khoon Tan, Maureen Shuh, Heather Francois-Vaughan, et al.
Ochsner Journal|May 24, 2011
Improving Donor Livers by Inhibiting TNF-α ProductionChristopher P Zetzmann, O Rama Swamy, George E Loss, et al.
Frontiers in Oncology|July 5, 2022
Distinct Gene Expression Profiles in Viable Hepatocellular Carcinoma Treated With Liver-Directed TherapyKelley G Núñez, Tyler Sandow, Meredith A Lakey, et al.
Cancers|April 12, 2022
Hypoalbuminemia Is a Hepatocellular Carcinoma Independent Risk Factor for Tumor Progression in Low-Risk Bridge to Transplant CandidatesKelley G Núñez, Tyler Sandow, Jai Patel, et al.
Ochsner Journal|March 24, 2017
Antibody-Mediated Rejection: A ReviewJorge Carlos Garces, Sixto Giusti, Catherine Staffeld-Coit, et al.
Cancer Immunology, Immunotherapy : CII|October 24, 2021
PD-1 expression in hepatocellular carcinoma predicts liver-directed therapy response and bridge-to-transplant survivalKelley G Núñez, Tyler Sandow, Daniel Fort, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2023
Lineage-specific regulation of PD-1 expression in early-stage hepatocellular carcinoma following 90yttrium transarterial radioembolization - Implications in treatment outcomesKelley G Núñez, Tyler Sandow, Juan Gimenez, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 31, 2002
Preliminary results: outcome of liver transplantation for hepatitis B virus varies by hepatitis B virus genotypeHarshad C Devarbhavi, Ari J Cohen, Robin Patel, et al.
Cancers|October 13, 2021
Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular CarcinomaKelley G Núñez, Tyler Sandow, Daniel Fort, et al.
Cancers|January 11, 2024
Imaging Delay Following Liver-Directed Therapy Increases Progression Risk in Early- to Intermediate-Stage Hepatocellular CarcinomaJordin Stanneart, Kelley G Nunez, Tyler Sandow, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Ochsner Journal|March 24, 2017
Negligible Oval Cell Proliferation Following Ischemia-Reperfusion Injury With and Without Partial HepatectomyEk Khoon Tan, Maureen Shuh, Heather Francois-Vaughan, et al.
Ochsner Journal|May 24, 2011
Improving Donor Livers by Inhibiting TNF-α ProductionChristopher P Zetzmann, O Rama Swamy, George E Loss, et al.
Frontiers in Oncology|July 5, 2022
Distinct Gene Expression Profiles in Viable Hepatocellular Carcinoma Treated With Liver-Directed TherapyKelley G Núñez, Tyler Sandow, Meredith A Lakey, et al.
Cancers|April 12, 2022
Hypoalbuminemia Is a Hepatocellular Carcinoma Independent Risk Factor for Tumor Progression in Low-Risk Bridge to Transplant CandidatesKelley G Núñez, Tyler Sandow, Jai Patel, et al.
Ochsner Journal|March 24, 2017
Antibody-Mediated Rejection: A ReviewJorge Carlos Garces, Sixto Giusti, Catherine Staffeld-Coit, et al.
Cancer Immunology, Immunotherapy : CII|October 24, 2021
PD-1 expression in hepatocellular carcinoma predicts liver-directed therapy response and bridge-to-transplant survivalKelley G Núñez, Tyler Sandow, Daniel Fort, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2023
Lineage-specific regulation of PD-1 expression in early-stage hepatocellular carcinoma following 90yttrium transarterial radioembolization - Implications in treatment outcomesKelley G Núñez, Tyler Sandow, Juan Gimenez, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 31, 2002
Preliminary results: outcome of liver transplantation for hepatitis B virus varies by hepatitis B virus genotypeHarshad C Devarbhavi, Ari J Cohen, Robin Patel, et al.
Cancers|October 13, 2021
Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular CarcinomaKelley G Núñez, Tyler Sandow, Daniel Fort, et al.
Cancers|January 11, 2024
Imaging Delay Following Liver-Directed Therapy Increases Progression Risk in Early- to Intermediate-Stage Hepatocellular CarcinomaJordin Stanneart, Kelley G Nunez, Tyler Sandow, et al.
Pageof 5